![Dhaval Desai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dhaval Desai
Corporate Officer/Principal bei
4D MOLECULAR THERAPEUTICS, INC.
Profil
Dhaval Desai currently works at 4D Molecular Therapeutics, Inc., as Chief Development Officer from 2024.
Dr. Desai also formerly worked at Thrombogenics, Inc., as Global Director-Medical Affairs from 2011 to 2014, Aerpio Therapeutics, Inc., as Vice President-Medical Affairs, Novartis AG, as Vice President & Head-US Ophthalmics from 2018 to 2020, Aerpio Pharmaceuticals, Inc., as Chief Strategy Officer & VP-Medical Affairs from 2014 to 2018, and IVERIC bio, Inc., as Chief of Staff from 2020 to 2021.
Dr. Desai received his doctorate degree from Rutgers State University of New Jersey.
Aktive Positionen von Dhaval Desai
| Unternehmen | Position | Beginn |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 25.09.2024 |
Ehemalige bekannte Positionen von Dhaval Desai
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.08.2020 |
| AERPIO PHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Corporate Officer/Principal | 01.07.2014 |
| IVERIC BIO, INC. | Personalreferent | 01.04.2021 |
Aerpio Therapeutics LLC
 Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dhaval Desai
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Aerpio Therapeutics LLC
Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
